Thus, our work shows that the lower number of infiltrating monocytes in CCR2−/− is partially compensated by increased proliferation of resident alveolar macrophages during the inflammation control of experimental ARDS. The gene discussed is CCR2; the disease is acute respiratory distress syndrome.